← FDA DRUG APPROVALS

FDA ANDA · ANDA085827

HYDRALAZINE AND HYDROCHLOROTHIAZIDE

Sponsor: WATSON LABS

APPLICATION
ANDA085827
TYPE
ANDA
LATEST ACTION
1986-07-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HYDRALAZINE AND HYDROCHLOROTHIAZIDEDiscontinued
HYDRALAZINE HYDROCHLORIDE 25MG, HYDROCHLOROTHIAZIDE 15MG · TABLET · ORAL

Approval history

1986-07-11Manufacturing (CMC) · Supplement 8AP
1986-03-04Manufacturing (CMC) · Supplement 7AP
1984-03-27Manufacturing (CMC) · Supplement 6AP
1983-08-22Manufacturing (CMC) · Supplement 5AP
1982-03-29Manufacturing (CMC) · Supplement 4AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →